Skip to main content

Advertisement

Log in

Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Lautropia mirabilis is a Gram-negative, facultative anaerobic coccus, which has been detected mainly in respiratory sites of immunodeficient patients suffering from HIV or cystic fibrosis. To date, knowledge about the pathogenicity of L. mirabilis is spare due to the small numbers of documented cases.

Methods

We present a literature review and report the case of a 39-year-old female diagnosed with common variable immunodeficiency (CVID) with IgG and IgA deficiency suffering from a sepsis with L. mirabilis. As no fully closed L. mirabilis genome besides the type strain was available to date, we additionally performed complete genome sequencing of L. mirabilis.

Results

The patient was admitted to our hospital with recurrent episodes of fever. Here, we detected L. mirabilis in two different blood cultures. The bacterium was tested susceptible to and treated with meropenem. As the origin of L. mirabilis sepsis, we observed an active periodontitis likely due to impaired IgA levels and mucosal insufficiency as a consequence of CVID. Whole genome sequencing of L. mirabilis revealed several genes important for host cell invasion and intracellular survival of the pathogen.

Conclusions

Our case highlights the importance of L. mirabilis in immunocompromised patients also in other compartments than the respiratory tract.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The genome sequence presented in this study can be found in online repositories (NCBI GenBank, Accession: CP146356, BioProject: PRJNA1081434, BioSample: SAMN40175934): https://www.ncbi.nlm.nih.gov/nuccore/CP146356. The 16S rRNA gene sequence was deposited separately at NCBI GenBank and can be accessed through OR468380: https://www.ncbi.nlm.nih.gov/nuccore/OR468380. The bacterial isolate was deposited in the open collection of the Leibniz Institute DSMZ—German Collection of Microorganisms and Cell Cultures GmbH, was confirmed as L. mirabilis and assigned the identifier DSM Lautropia mirabilis 512852 (DSM 117694).

References

  1. Gerner-Smidt P, Keiser-Nielsen H, Dorsch M, Stackebrandt E, Ursing J, Blom J, Christensen AC, Christensen JJ, Frederiksen W, Hoffmann S, et al. Lautropia mirabilis gen. nov., sp. nov., a gram-negative motile coccus with unusual morphology isolated from the human mouth. Microbiology (Reading). 1994;140:1787–97. https://doi.org/10.1099/13500872-140-7-1787.

    Article  CAS  PubMed  Google Scholar 

  2. Orskov J. Untersuchungen über einen in Mundhöhle und oberen Luftwegen häufig vorkommenden, zur Sarcinagruppe gehörigen Mikroben, der eigentümliche morphologische Verhältnisse aufweist. Acta Pathol. Microbiol. Scand.(Suppl. III). 1930;519–41.

  3. Rossmann SN, Wilson PH, Hicks J, Carter B, Cron SG, Simon C, Flaitz CM, Demmler GJ, Shearer WT, Kline MW. Isolation of Lautropia mirabilis from oral cavities of human immunodeficiency virus-infected children. J Clin Microbiol. 1998;36:1756–60. https://doi.org/10.1128/JCM.36.6.1756-1760.1998.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ben Dekhil SM, Peel MM, Lennox VA, Stackebrandt E, Sly LI. Isolation of Lautropia mirabilis from sputa of a cystic fibrosis patient. J Clin Microbiol. 1997;35:1024–6. https://doi.org/10.1128/jcm.35.4.1024-1026.1997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Daneshvar MI, Douglas MP, Weyant RS. Cellular fatty acid composition of Lautropia mirabilis. J Clin Microbiol. 2001;39:4160–2. https://doi.org/10.1128/JCM.39.11.4160-4162.2001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tan RYP, Tan BQ, Rao N. The first case of peritoneal dialysis-associated peritonitis due to Lautropia mirabilis. Nephrology (Carlton). 2021;26:634–5. https://doi.org/10.1111/nep.13866.

    Article  PubMed  Google Scholar 

  7. Calheiros Cruz G, Sousa M, Vilela S, Teixeira E, Costa F, Silva FJ. Lautropia mirabilis: an exceedingly rare cause of peritoneal dialysis-associated peritonitis. Case Rep Nephrol Dial. 2022;12:81–4. https://doi.org/10.1159/000524494.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liu S, Yan Y, Hu C, Huang X, Liu Q, Liu Y, Jia N, Han C. Lautropia mirabilis-induced peritoneal dialysis-associated peritonitis: a case report. 2023; https://doi.org/10.21203/rs.3.rs-2766634/v1

  9. Gerner-Smidt P, Keiser-Nielsen H, Dorsch M, Stackebrandt E, Ursing J, Blom J, Christensen AC, Christensen JJ, Frederiksen W, Hoffmann S, Holten-Andersen W. Lautropia mirabilis gen. nov., sp. nov., a gram-negative motile coccus with unusual morphology isolated from the human mouth. Microbiology. 1994;140:1787–97.

    Article  CAS  PubMed  Google Scholar 

  10. Riediger M, Hoffmann K, Isberner R, Dreyer A, Tersteegen A, Marquardt P, Kaasch AJ, Zautner AE. Chimaeribacter arupi a new member of the Yersineacea family has the characteristics of a human pathogen. Front Cell Infect Microbiol. 2023;13:1277522. https://doi.org/10.3389/fcimb.2023.1277522.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Voronina OL, Kunda MS, Ryzhova NN, Aksenova EI, Sharapova NE, Semenov AN, Amelina EL, Chuchalin AG, Gintsburg AL. On Burkholderiales order microorganisms and cystic fibrosis in Russia. BMC Genomics. 2018;19:74. https://doi.org/10.1186/s12864-018-4472-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. National Institute of Allergy and Infectious Diseases: https://www.niaid.nih.gov/diseases-conditions/common-variable-immunodeficiency-cvid, 19.08.2024; 08:37am

  13. American Academy of Allergy Asthma & Immunology: https://www.aaaai.org/conditions-treatments/primary-immunodeficiency-disease/common-variable-immunodeficiency, 19.08.2024; 08:38am

Download references

Acknowledgements

We thank F. Meier, S. Jürgenfeldt, N. Schlüter and L. Siegmann for technical support and G. Geginat, K. Borucki and B. Schraven for critical discussion.

Funding

This work was supported by grants of the federal state of Saxony-Anhalt, Germany (SI2 and SI3) to the assistant professorship “Inflammation and Immunometabolism” (to. S.K.).

Author information

Authors and Affiliations

Authors

Contributions

Supervision: S.K. with T.E. and A. E. Z.; Drafting, Writing, and Experimentation: S.G. with S.K.; Clinical treatment: M.B., E.S., T.E.; MALDI-TOF identification and 16S Sequencing: A.Z. and J.F.; Image acquisition: B.M.; Significant intellectual input and expert opinion: A.J.K.; Editing, Approval of the final manuscript: All authors.

Corresponding authors

Correspondence to Andreas E. Zautner, Torben Esser or Sascha Kahlfuß.

Ethics declarations

Competing interests

The authors declare no competing interests.

Consent to participate

As the data presented are retrospective and represent an incidental finding during routine clinical care, and no investigational interventions were performed, informed consent was not obtained for this anonymous case report.

Consent to publish

As the patient was lost to follow-up, no consent for publication could be given. The publication of anonymous, retrospective, and routine clinical data is in line with the general terms and conditions of the Magdeburg University Hospital. Identification of the patient on the basis of the data provided is not possible.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 KB)

Supplementary file2 (DOCX 28 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genseke, S., Berisha, M., Teerstegen, A. et al. Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features. Infection (2024). https://doi.org/10.1007/s15010-024-02388-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s15010-024-02388-6

Keywords

Navigation